Lange CA

ORCID: 0000-0003-2751-3976 · 5 papers in corpus · active 2011-2023
2023
Steroids ·doi:10.1016/j.steroids.2023.109329

Progesterone and progestin agonists are potent steroid hormones. There are at least three major types of progesterone receptor (PR) families that interact with and respond to progesterone or progestin ligands. These receptors include ligand…

2023
Endocrine reviews ·doi:10.1210/endrev/bnad018

Ovarian cancer (OC) represents a collection of rare but lethal gynecologic cancers where the difficulty of early detection due to an often-subtle range of abdominal symptoms contributes to high fatality rates. With the exception of BRCA1/2 …

2015
Journal of molecular endocrinology ·doi:10.1530/jme-14-0252

Progesterone and progesterone receptors (PRs) are essential for the development and cyclical regulation of hormone-responsive tissues including the breast and reproductive tract. Altered functions of PR isoforms contribute to the pathogenes…

2014
Pharmacology & therapeutics ·doi:10.1016/j.pharmthera.2013.11.010

Ovarian steroid hormones contribute to breast cancer initiation and progression primarily through the actions of their nuclear transcription factors, the estrogen receptor alpha (ERα) and progesterone receptors (PRs). These receptors are im…

2011
Expert review of endocrinology & metabolism ·doi:10.1586/eem.11.25

The ovarian steroid hormones, estradiol and progesterone, and their nuclear receptors (estrogen receptor [ER] and progesterone receptor [PR]), are involved in breast cancer development. As ER-positive/PR-positive tumors progress, they are l…